Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: What have we learned?

Journal of Hospital Infection

Volumn 47, Issue 1, 2001, Pages 9-18

  Rubinovitch, B ^a   Pittet, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Admission screening; Cost effectiveness; Endemic MRSA; Infection control; Methicillin resistant Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; DISINFECTANT AGENT; METICILLIN; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; COST EFFECTIVENESS ANALYSIS; ENDEMIC DISEASE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; INFECTION CONTROL; INFECTION RATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW;

EID: 0035142596     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2000.0873     Document Type: Review

References (74)

1. A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals
2. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991
3. Methicillin-resistant Staphylococcus aureus in Europe
4. Report: Data summary from October 1986 - April 1996
5. Living with methicillin-resistant Staphylococcus aureus: A 7-years experience with endemic MRSA in a university hospital
6. Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents
7. Methicillin-resistant Staphylococcus aureus in two child care centers
8. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resisrant Staphylococcus aureus in a northern Australian hospital
9. Should we try vigorously to contain and control MRSA?
10. Methicillin-resistant Staphylococcus aureus: Implications for the 1990s and effective control measures
11. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management
12. Methicillin-resistant Staphylococcus aureus control in hospitals: The Dutch experience
13. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995
14. Revised guidelines for the control of Methicillin-resistant Staphylococcus aureus infection in hospitals
15. Control of methicillin-resistant Staphylococcus aureus in the hospital setting
16. Improved understanding and control of nosocomial methicillin-resistant Staphylococcus aureus: Are we overdoing it?
17. Is it time to stop searching for MRSA? Stop the ritual of tracing colonised people
18. Methicillin-resistant Staphylococcus aureus (MRSA) - A re-appraisal of control measures in the light of changing circumstances
19. The population impact of MRSA in a country: The national survey of MRSA in Wales, 1997
20. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk
21. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community
22. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors
23. Community strain of methicillin-resistent Staphylococcus aureus involved in a hospital outbreak
24. Increase in community-acquired methicillin-resistant Staphylococcus aureus at a Naval Medical Centre
25. A seven-year experience with methicillin-resistant Staphylococcus aureus
26. Winning the battle but losing the war: Methicillin-resistant Staphylococcus aureus infection at a teaching hospital
27. Cost-containment using an outcome-based best practice model for the management of MRSA
28. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus
29. Methicillin-resistant Staphylococcus aureus - A suitable case for inactivity?
30. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus
31. Increasing prevalence of Methicillinresistant Staphylococcus aureus in the United States
32. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus
33. Methicillin-resistant Staphylococcus aureus
34. Methicillin-resistant Staphylococcus aureus: Colonisation and infection in a long-term care facility
35. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility
36. Control of methicillin-resistant Staphylococcus aureus at a university hospital: One decade later
37. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
38. Staphylococcus aureus nasal colonisation and association with infections in liver transplant recipients
39. Relationship between antibiotic resistance, the production of 'virulence factors' and virulence for experimental animals in Staphylococcus aureus
40. Methicillin-resistant strains of Staphylococcus aureus: Relation between expression of resistance and phagocytosis by polymorphonuclear leukocytes
41. Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain
42. Production of 'virulence factors' by 'epidemic' methicillin-resisrant Staphylococcus aureus in-vitro
43. Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains
44. Comparison of in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells
45. Enterotoxin and toxic shock toxin syndrome toxin-1 production of methicillin resistant and methicillinsensitive Staphylococcus aureus strains
46. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital
47. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
48. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
49. Nosocomial methicillinresistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what cost?
50. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD
51. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus
52. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci
53. A control programme for MRSA (methicillinresistant Staphylococcus aureus) containment in a paediatric intensive care unit: Evaluation and impact on infections caused by other micro-organisms
54. Staphylococcus aureus and vancomycin: The sequel
55. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
56. Recurrent methicillin-resistant Staphylococcus aureus osteomyelitis: Combination antibiotic therapy with evaluation by serum bactericidal titers
57. Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy
58. Use of linezolid, an oxazolidinone, in the treatment of multidrugresistant Gram-positive bacterial infections
59. Vancomycin-resistant enterococcal infections
60. Clinical implications of nosocomial Gram-positive bacteria and superimposed antimicrobial resistance
61. New resistance in Staphylococcus aureus
62. The decline of methicillin resistance among Danish Staphylococcus aureus strains
63. Assigning responsibility: Using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus
64. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance - Role of hospital information system
65. Effectiveness of a hospital-wide programme to improve compliance with hand-hygiene
66. Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas
67. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high risk hospital areas with a high level of endemic MRSA
68. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective?
69. Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit
70. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals
71. To Control or not to control colonisation with MRSA...that's the question!
72. Is it time to stop searching for MRSA? Screening is still important
73. Effectiveness of contact isolation during a hospital outbreak of methicillinresistant Staphylococcus aureus
74. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission